Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial.
about
Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight yearsConventional occlusion versus pharmacologic penalization for amblyopia.The relationship between anisometropia and amblyopiaPerceptual learning as a potential treatment for amblyopia: a mini-reviewBinocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight yearsThe challenges of amblyopia treatmentEvaluating the burden of amblyopia treatment from the parent and child's perspectiveRetinal nerve fiber layer thickness in amblyopic eyesA randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children.Laterality of amblyopiaStereopsis and amblyopia: A mini-review.Light transmission and preference of eye patches for occlusion treatmentPrevalence of amblyopia in primary school children in Qassim province, Kingdom of Saudi ArabiaEffect of age on response to amblyopia treatment in children.A randomized trial of levodopa as treatment for residual amblyopia in older childrenStereoacuity in children with anisometropic amblyopia.Designing clinical trials for amblyopiaTreatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trials.Amblyopia therapy: an update.Patient-reported outcome measures (PROMs) in paediatric ophthalmology: a systematic review.Deprivation amblyopia and congenital hereditary cataract.Effect of a Binocular iPad Game vs Part-time Patching in Children Aged 5 to 12 Years With Amblyopia: A Randomized Clinical Trial.Brain adaptation and alternative developmental trajectories.A computer-based anaglyphic system for the treatment of amblyopia.Treatment of Amblyopia Using Personalized Dosing Strategies: Statistical Modelling and Clinical Implementation.Paediatric Eye Services: How Much of the Workload Is Amblyopia-Related?Limitations of the TheraMon® -microsensor in monitoring occlusion therapy.Longitudinal Impact on Quality of Life for School-aged Children with Amblyopia Treatment: Perspective from Children.Refractory reverse amblyopia with atropine penalization.Pharmacological therapy for amblyopia.Short-term effects of vision trainer rehabilitation in patients affected by anisometropic amblyopia: electrofunctional evaluation.Treating amblyopia in adults with prosthetic occluding contact lenses.Outcome of conventional treatment for adult amblyopia.Screening of Primary School Children for Amblyopia and Amblyogenic Factors in Central Cairo, Egypt.Improved Binocular Outcomes Following Binocular Treatment for Childhood Amblyopia.Fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia
P2860
Q24187940-72F87578-B132-49EA-AEC0-3E18622CF5DCQ24240182-1054252B-9E93-4F5B-93E2-43E2E53C4393Q24621632-F00FDC56-D29B-4833-878D-A0F944C6D5B2Q24651081-BA213413-3CC0-40A2-8B0A-B6B3A9AA27A8Q26471258-49B85C11-469B-47BE-A310-BEE72F9E1763Q26751335-51A281B2-167E-4064-BDF3-BCBACA728B24Q30497767-9A6D0AAD-B77B-4754-B498-A41E1E78ABBCQ33786501-8D38C801-B382-48C6-86EE-EF752B018DBAQ33828891-A93CDB9C-04F0-4278-A7D6-82845B3EDCEEQ34031773-31ABC28D-4C1F-44FF-944D-EA39409620F7Q34460690-8D727196-6F9D-4CEB-A577-8E6FC0CE2382Q34795213-47397DCB-9000-447E-9A08-B744956CEC84Q34997738-92212EC5-2DBF-49C3-B785-E10DCF0248C4Q35552461-FDB07EB9-7C0E-4820-9B57-392CCFE21A60Q35554029-B6D947A3-55DA-45AD-B0CA-FC3B87B0D9BAQ35571097-FE779E6C-0BDF-46D8-BEE3-1384D9521940Q35995378-B8A07DB4-3085-4F32-AE3C-B6FC4E180A99Q37268103-DC30FE4A-D9CF-4014-8383-2690BC5256A1Q37922780-3BEAF5E9-2E22-46BD-B0B9-047AC86FF493Q38112550-91E311BF-FC7A-41D9-B0E6-63AC6A5BE15BQ38153728-C8A8BE04-4391-4D17-A682-A467C893DC1EQ38385129-BB01D82F-D2C6-4607-BE32-E98B82B8D8D5Q38495771-CCF749DD-4120-431D-9BD5-ED36E21A8129Q38566006-B8F5A688-E6D1-4A39-B750-2E24D62195B5Q38785756-1A242901-9667-4921-BB9C-F8503D344986Q39490728-C4B4605C-FA7E-47AD-BCCE-667CAB13EF21Q40679269-BF84BE97-F57A-459D-B805-DBC191CC5425Q41171113-2066380B-C46E-406B-8172-79985A1881B7Q41505023-321935A4-C590-4998-8C42-35182C7E0CBBQ42359951-551C5A89-BA58-4427-B9E0-FE78BBEFB1B5Q46045290-0D42E8C5-9B57-4398-B766-8E6015E1592EQ47213120-5C3C3D1C-8C76-4781-8C9F-6808A347DE09Q48912245-9CC9C30E-51F6-457B-A001-B2A8BD97218EQ55085714-2397D195-BE2C-4792-88FA-50926CEBA5BAQ55235708-5039B1B9-3940-4958-84F5-5670600C105CQ58701350-307DA561-90F0-41F1-A76C-712BC281DE51
P2860
Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Patching vs atropine to treat ...... 12 years: a randomized trial.
@ast
Patching vs atropine to treat ...... 12 years: a randomized trial.
@en
type
label
Patching vs atropine to treat ...... 12 years: a randomized trial.
@ast
Patching vs atropine to treat ...... 12 years: a randomized trial.
@en
prefLabel
Patching vs atropine to treat ...... 12 years: a randomized trial.
@ast
Patching vs atropine to treat ...... 12 years: a randomized trial.
@en
P2093
P2860
P1433
P1476
Patching vs atropine to treat ...... o 12 years: a randomized trial
@en
P2093
David G Morrison
Eileen E Birch
James Kundart
Jonathan M Holmes
Michael X Repka
Mitchell M Scheiman
Pediatric Eye Disease Investigator Group
Raymond T Kraker
Richard W Hertle
Roy W Beck
P2860
P304
P356
10.1001/ARCHOPHTHALMOL.2008.107
P407
P50
P577
2008-12-01T00:00:00Z